December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by CytoAgents, Inc.

News headline image
CytoAgents Appoints Dr. Johannes Wolff as Chief Medical Officer and Michael Howell as Chief Scientific Officer
From CytoAgents, Inc.
Via Business Wire
News headline image
CytoAgents to Present New CTO1681 Data at the ESMO Immuno-Oncology Congress 2025
From CytoAgents, Inc.
Via Business Wire
News headline image
CytoAgents Announces Poster Presentation of New CTO1681 Clinical Data at the 67th American Society of Hematology Annual Meeting
From CytoAgents, Inc.
Via Business Wire
News headline image
CytoAgents Receives Fourth Grant From National Institutes of Health to Advance Research on Cytokine Release Syndrome
From CytoAgents, Inc.
Via Business Wire
News headline image
CytoAgents Announces Appointment of New Chief Medical Officer
From CytoAgents, Inc.
Via Business Wire
News headline image
CytoAgents’ Phase 1 Trial Results Show “Cytokine Release Syndrome” Drug Candidate Safe
From CytoAgents, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.